Diagnosing Double Vision

July 11, 2018

One of the golden rules of Trial Master File (TMF) management is to avoid duplicate filing of documents.  We all know that the primary objectives of the TMF is to provide step-by-step documentation of the clinical trial and to protect the rights of patients.  It is also vitally important for the TMF to facilitate, and…

Read More

Self-Deception — The 3 Most-Repeated Lies Of Trial Master File QC

July 11, 2018

Achieving inspection readiness means that during all stages of a clinical trial, a regulatory inspector would be able to walk into the building and reconstruct the trial using only the documents and metadata present in the Trial Master File (TMF). Although the concept of an inspection-ready TMF may be simply described, inspection readiness is not…

Read More

Nontransferable Obligations: Why Sponsors Fail Inspections Part One: Lack of Oversight

June 28, 2018

Discussion of FDA inspections, whether for cause or part of a routine GCP inspection, usually centers on the inspection of trial sites and the CROs who are tasked with managing them. The reason for the disproportionate focus on the inspection of trial sites and CROs stems from two material factors: the patient centered nature of…

Read More

TOP 10 Things to do for DIA 2018 in Boston

June 21, 2018

Come meet LMK at booth 823 at DIA! We think it’s fitting that an event that will shape the future of the pharmaceutical industry is held in a city that is both entrenched in the history of our country and fully committed to the innovations of the future. Although LMK isn’t local to Boston, we…

Read More

Have More Than Faith: Have Conviction

June 18, 2018

A Message from Sholeh Ehdaivand President and CEO of LMK Clinical Research Consulting Sometimes when we are watching TV together, and an ad for a new drug comes on screen, my kids will ask, ‘Mom did you work on that?’ Sometimes I can say, yes I did! My first step as an entrepreneur was made…

Read More

Top 10 reasons to implement the TMF Reference Model

May 27, 2018

In anticipation of the release of version 3 of the TMF Reference Model and in honor of David Letterman’s last “Late Show” appearance, this post mimics his famous Top 10 list. Here are the Top 10 reasons to implement the TMF Reference Model. Enjoy! #10. You can finally answer the question “does this document belong…

Read More

Three Key Conclusions: New MHRA GCP Inspection Metrics

May 25, 2018

Great Britain’s MHRA (Medicines and Healthcare products Regulatory Agency) is known (and feared) for their high expectations regarding the TMF. MHRA expects your TMF to be “the story of how the trial was conducted and managed.” Their “inspectors want to reconstruct the trial conduct so that it can be evaluated for compliance …[and] review any…

Read More

A Series of Unfortunate Events… In the TMF

April 27, 2018

“No-one goes to work to do a bad job!” This quote, penned by legendary management thinker W. Edwards Deming, was introduced to us by a friend of LMK, process improvement and human factors guru, Keith Dorricott. In a recent LMK webinar, Keith discussed best practices for TMF metrics, and arrived at the conclusion that this…

Read More

Is Your TMF Ready For GDPR? Part Three: Know Your Responsibilities

April 17, 2018

Is your TMF ready for GDPR? This is the third and final post of a series examining how the new European Union General Data Protection Regulation could affect your trial master file. See part one and part two which examine the basic roles within GDPR and the foundational rights of data subjects. Serious Penalties and…

Read More